Fig. 5From: Myeloid dendritic cells are decreased in peripheral blood of Alzheimer’s disease patients in association with disease progression and severity of depressive symptomsTreatment with AChEI modulates the level of mDCs in AD patients. The distribution of percentage values of mDCs (a) and pDCs (b) present in the blood of HC (n = 73), AD without AChEI treatment (n = 40), and AD treated with AChEI (n = 66) is reported in the respective scatter dot plot, as indicated. The black bars indicate the mean. *p < 0.0001Back to article page